Skip to content

Clinical trials

Phase 2 Hidradenitis Suppurativa trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hidradenitis Suppurativa Phase: Phase 2 Country / region: Germany Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20151
20171
20183
20192
20201
20214
20222
20233
20242
20257
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting5
Active, not recruiting4
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi4
AbbVie2
Boehringer Ingelheim2
Incyte Corporation2
InflaRx GmbH2
Janssen Research & Development, LLC2
Novartis Pharmaceuticals2
ACELYRIN Inc.1
Abbott1
Avalo Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hidradenitis Suppurativa29
Skin Diseases4
Hidradenitis3
Skin Diseases, Bacterial2
Sweat Gland Diseases2
Abscess1
Acne Vulgaris1
Chronic Urticaria1
Dermatitis1
Fistula1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.